Table 3.
Between hospital critical care: Hospital 1 versus Hospital 2 |
Between hospital wards: Hospital 1 versus Hospital 2 |
Within Hospital 1: critical care versus wards |
Within Hospital 2: critical care versus wards |
Renal: inpatients versus outpatients |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Enterobacteriaceae, ESBL/AmpC phenotype | 2009–10 | * | 2009–10 | NS | 2009–10 | *** | 2009–10 | *** | 2009–10 | ** |
2010–11 | *** | 2010–11 | NS | 2010–11 | NS | 2010–11 | *** | 2010–11 | *** | |
2011–12 | NS | 2011–12 | *** | 2011–12 | *** | 2011–12 | *** | 2011–12 | *** | |
2012–13 | * | 2012–13 | ** | 2012–13 | *** | 2012–13 | *** | 2012–13 | *** | |
Enterobacteriaceae, ciprofloxacin non-susceptible | 2009–10 | NS | 2009–10 | * | 2009–10 | NS | 2009–10 | NS | 2009–10 | *** |
2010–11 | * | 2010–11 | * | 2010–11 | ** | 2010–11 | NS | 2010–11 | *** | |
2011–12 | NS | 2011–12 | ** | 2011–12 | * | 2011–12 | NS | 2011–12 | *** | |
2012–13 | NS | 2012–13 | * | 2012–13 | NS | 2012–13 | NS | 2012–13 | *** | |
Pseudomonas spp., ciprofloxacin non-susceptible | 2009–10 | NS | 2009–10 | NS | 2009–10 | * | 2009–10 | * | 2009–10 | * |
2010–11 | NS | 2010–11 | *** | 2010–11 | NS | 2010–11 | * | 2010–11 | *** | |
2011–12 | NS | 2011–12 | NS | 2011–12 | ** | 2011–12 | *** | 2011–12 | * | |
2012–13 | * | 2012–13 | * | 2012–13 | NS | 2012–13 | *** | 2012–13 | NS | |
Pseudomonas spp., piperacillin/tazobactam non-susceptible | 2009–10 | *** | 2009–10 | NS | 2009–10 | NS | 2009–10 | *** | 2009–10 | *** |
2010–11 | NS | 2010–11 | * | 2010–11 | *** | 2010–11 | *** | 2010–11 | *** | |
2011–12 | NS | 2011–12 | NS | 2011–12 | NS | 2011–12 | *** | 2011–12 | NS | |
2012–13 | NS | 2012–13 | * | 2012–13 | NS | 2012–13 | *** | 2012–13 | NS | |
Pseudomonas spp., meropenem non-susceptible | 2009–10 | NS | 2009–10 | NS | 2009–10 | *** | 2009–10 | *** | 2009–10 | *** |
2010–11 | *** | 2010–11 | ** | 2010–11 | *** | 2010–11 | *** | 2010–11 | *** | |
2011–12 | * | 2011–12 | NS | 2011–12 | *** | 2011–12 | *** | 2011–12 | NS | |
2012–13 | * | 2012–13 | * | 2012–13 | *** | 2012–13 | *** | 2012–13 | ** | |
Enterococcus spp., glycopeptide non-susceptible | 2009–10 | * | 2009–10 | *** | 2009–10 | *** | 2009–10 | *** | 2009–10 | *** |
2010–11 | NS | 2010–11 | ** | 2010–11 | *** | 2010–11 | *** | 2010–11 | *** | |
2011–12 | NS | 2011–12 | ** | 2011–12 | ** | 2011–12 | *** | 2011–12 | *** | |
2012–13 | NS | 2012–13 | ** | 2012–13 | *** | 2012–13 | * | 2012–13 | *** | |
Enterococcus spp., amoxicillin non-susceptible | 2009–10 | NS | 2009–10 | *** | 2009–10 | ** | 2009–10 | *** | 2009–10 | *** |
2010–11 | NS | 2010–11 | *** | 2010–11 | ** | 2010–11 | *** | 2010–11 | *** | |
2011–12 | NS | 2011–12 | *** | 2011–12 | *** | 2011–12 | *** | 2011–12 | *** | |
2012–13 | ** | 2012–13 | *** | 2012–13 | *** | 2012–13 | ** | 2012–13 | *** | |
S. aureus, methicillin non-susceptible | 2009–10 | *** | 2009–10 | *** | 2009–10 | * | 2009–10 | NS | 2009–10 | * |
2010–11 | NS | 2010–11 | *** | 2010–11 | NS | 2010–11 | ** | 2010–11 | * | |
2011–12 | ** | 2011–12 | * | 2011–12 | NS | 2011–12 | *** | 2011–12 | NS | |
2012–13 | NS | 2012–13 | NS | 2012–13 | NS | 2012–13 | NS | 2012–13 | * |
NS, no significant difference.
*Significant at P < 0.05.
**Significant at P < 0.01.
***Significant at P < 0.001.